<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/ema-chmp-november-2026-meeting-highlights-biosimilars-generics</loc>
    <lastmod>2026-11-15T22:37:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>EMA CHMP Recommends Seven New Medicines Including Two Insulin Aspart Biosimilars in November 2026</news:title>
      <news:keywords>EMA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/304e27f8-60ad-45a9-95ef-4a7520e7a7bb/cada1ba0-46ac-4b64-a7c3-1b2f87a17a36.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/reviva-pharmaceuticals-secures-uspto-track-1-priority-examination-brilaroxazine-formulation-patent-2046</loc>
    <lastmod>2026-11-15T22:36:17+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>Reviva Pharmaceuticals Secures USPTO Priority Examination for Brilaroxazine</news:title>
      <news:keywords>Reviva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/482f42c5-35fd-4141-aed7-7d890380c154/2f7cf5f2-a0f9-49ec-934c-df9c55165b47.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sutro-biopharma-advances-three-adc-programs-cell-free-conjugation-platform</loc>
    <lastmod>2026-11-15T22:39:27+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>Sutro Biopharma Advances Three ADC Programs Toward Clinic Using Cell-Free Conjugation Platform</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5c5eb24d-61a5-45eb-a57f-5d93b52c1631/ef013cf0-7189-4887-9208-8b034a2ef3f3.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/codexis-eco-synthesis-100-gram-oligonucleotide-scale-up-gmp-2027</loc>
    <lastmod>2026-11-15T22:41:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>Codexis Achieves 100-Gram Oligonucleotide Scale-Up</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5c5eb24d-61a5-45eb-a57f-5d93b52c1631/a75cfab0-ee56-411a-8ca6-8bbc1e1f0bd7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/immix-biopharma-appoints-svp-cmc-regulatory-affairs-nxc-201-bla-2027</loc>
    <lastmod>2026-11-15T22:42:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>Immix Biopharma Appoints Dual SVPs to Lead CMC and Regulatory Affairs</news:title>
      <news:keywords>Immix</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.globenewswire.com/newsroom/ti?nf=OTg3NjY4OCM3OTYxMDg3IzUwMDA5ODEwNA==</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/eros-apothecary-recalls-candy-power-man-honey-undeclared-tadalafil</loc>
    <lastmod>2026-11-15T22:45:05+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T00:00:00+05:30</news:publication_date>
      <news:title>Eros Apothecary Recalls Honey Supplement After FDA Testing Finds Undeclared Tadalafil</news:title>
      <news:keywords>Eros</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0611c91f-7ba9-498c-aa81-d92d93fa4af8/4d193acf-20db-4efe-9ca4-f4a2acac33d0.png</image:loc>
    </image:image>
  </url>
</urlset>